Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

TSXV:BTI.H - Post Discussion

biOasis Technologies Ord Shs > PLX vol. 2.5 million shares with only 50 million outstanding
View:
Post by prophetoffactz on Feb 24, 2023 11:46am

PLX vol. 2.5 million shares with only 50 million outstanding


1.9150
+0.2150 (+12.65%)
As of 11:42AM EST. Market open.
Comment by Boomskid on Feb 24, 2023 12:23pm
I'm not surprised that the PLX share price has made such a modest move on the CHMP opinion. It's clear that the market knows that a pharma can't begin commercial operations with an opinion and that approval is required for revenue. With the great clinical results that Protalix and Chiesi have achieved with PRX-102, it will be no surprise to the market when they get FDA approval of the ...more  
Comment by prophetoffactz on Feb 24, 2023 12:38pm
"With the great clinical results that Protalix and Chiesi have achieved with PRX-102, it will be no surprise to the market when they get FDA approval of the drug. The delay in FDA approval was triggered by the FDA's inability to inspect Protalix's ProCellEx manufacturing and post-manufacturing facilities due to travel restrictions caused by Covid. Also, the situation with a PRX-102 ...more  
Comment by Boomskid on Feb 24, 2023 1:19pm
Good for Protalix, poof. Up almost double (90%). What does that have to do with Bioasis share price of 1.5¢? Yep, PRX was over $6 when they got a Complete Response Letter (CRL) from the FDA. Usually a CRL is fatal but not really so with PRX-102. Because of Covid, and because Protalix's submission was obsolete, and the FDA couldn't complete it's work before the extension, the CRL ...more  
Comment by prophetoffactz on Feb 24, 2023 1:50pm
US$138 million upfront and milestone payments is about C$186 million Canadian. Then there are the royalties. If the four licensed products have US$1.5 billion in revenue which is about C$2 billion at peak sales and BTI received a 5% royalty that is a potential C$100 million in royalties for one year at peak. Imagine three years that would be C$300 million. That would be C$486 million in upfront, ...more  
Comment by zwerp2000 on Feb 24, 2023 2:03pm
it's been 3 years and there has been no updates on any progress between bti and chiesi. bti has no money. the stock is trading at $.01. they can't pay their debt obligations and recently tried to sell the company for nothing to another company that was bankrupt. now remind me about this great deal bti has in place with chiesi. why isn't chiesi trying to buy bti out for peanuts so they ...more  
Comment by zwerp2000 on Feb 24, 2023 12:45pm
who cares? this has nothing to do with bti. notice how there is next to no volume on bti today and the stock is down. if there was really a connection, why no reaction from bti stock? stop your foolishness. you are a joke
Comment by ROSIE2023 on Feb 27, 2023 11:53am
Does BTI have anything on the go with PROTALIX
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities